Willingness to work in disasters is context-specific and corresponds to the nature, magnitude, and threats posed by a particular public health emergency. None us is certain that our health professionals will continue to provide service should the COVID-19 pandemic crisis climb to its worst level. It was with this uncertainty in mind that this study was done to assess predictors of the unwillingness of health-care workers (HCWs) to continue providing their professional services during the climax of the COVID-19 crisis. Methods: This was a facility-based descriptive cross-sectional study undertaken among 633 HCWsin western Ethiopia. Results: Overall, 205 (32.4%) providers said that they would be unwilling to continue work if COVID-19 peaked. Of these, 176 (27.9%) respondents reported that they would stop going in to work before they were at greatest risk. Statistical analysis performed to predict HCWs unwillingness' to continue work at peak COVID-19 showed male sex (AOR 11.4, 95% CI 8.32-12.6), younger age (AOR 25.3, 95% CI 4.61-40.67), lack of experience in handling similar pandemics (AOR 5.15, 95% CI 1.1-255), and low perceived level of hospital preparedness (AOR 2.05, 95% CI 0.80-5.21) were predictors of unwillingness. In accordance with the extended parallel-process model, higher threat perception (P≤0.001) and low efficacy perception (P≤0.040) were associated with unwillingness of the HCWs to continue working. Conclusion: The proportion of HCWs unwilling to continue their job during COVID-19 is sufficient to affect efforts tof fight the pandemic. As the question of whether our HCWs must risk themselves to treat COVID-19 patients does not have a uniform answer, working on predictors of potential unwillingness is of paramount importance.
Background Non-adherence to tuberculosis treatment is the most challenging and hindering factor for successful tuberculosis therapy. The long duration of tuberculosis treatment and the undesirable effects of anti-tuberculosis drugs result in non-adherence to treatment among pediatric patients. Hence, this study was aimed to evaluate pediatrics adherence status among tuberculosis pediatric patients on anti-tuberculosis treatment at Nekemte Specialized Hospital. Methods A health facility-based cross-sectional study design was used to recruit pediatric TB patients who were receiving their treatment between February 15 and March 15, 2019. Adherence to tuberculosis therapy was evaluated using data obtained from face-to-face interviews of their respective caregivers. The collected data were entered into EPI-manager 4.0.2 software and analyzed using SPSS version 24. Logistic regression was used to analyze the variables and variables with p-value <0.05 had a statistically significant association with the adherence to anti TB treatment. Results Among 202 participants involved in the study, 120 (59.4%) of them were males and 119 (58.9%) were in the age category of 11–15 years. A total of 166 (82.2%) of the patients had extra-pulmonary tuberculosis and 174 (86.1%) of them were in the intensive phase. Of the pediatric tuberculosis patients, 48 (73.3%) of them have adhered to the treatment regimen. Female gender [AOR: 3.3, 95% CI: 1.52–7.2], younger age (0–5 years) [AOR: 5.96 95% CI: 1.81–19.6], living in urban area [AOR: 3.73, 95% CI: 1.67–8.36], and patients who did not experience side effect [AOR: 2.87, 95% CI: 1.41–5.81] were predictors of good adherence to tuberculosis treatment up on multivariable logistic regression analysis. Conclusion The level of adherence observed in our study area was low. Age, sex, residence, and side effect experience showed an association with tuberculosis treatment adherence. Therefore, health care providers should educate all patients with tuberculosis before the initiation of anti-tuberculosis treatment.
Introduction: Ensuring the quality of pharmaceutical services in hospitals is an integral aspect of providing quality of health care. In this regard, it has long been proven that the adoption of the concept of pharmaceutical care is essential to improve the quality of pharmaceutical services. Hence, this study aimed to assess type 2 diabetes mellitus patients’ satisfaction with pharmacy services in Wollega University Referral Hospital, West Ethiopia. Methods: Descriptive cross-sectional study design was employed from May to June 2019. Data were collected using both close and open-ended questionnaires from the sample of type 2 diabetes mellitus patients. The collected data were analyzed using Statistical Package for Social Science version 20 and Descriptive data were explained by frequency and percentage. Results: From a total of 195 study participants, 124 (64%) were satisfied with pharmacy service. Patients who were satisfied with pharmacy services reported possible reasons like availability of the prescribed drugs, affordability, and notice of information on the drug package that is not taken with foods. However, patients were dissatisfied with other pharmacy related factors like the reflection of negative attitude from the pharmacists and withholding information on what to do during the occurrences of adverse effects. About two thirds (67.8%) patients agreed with the availability of prescribed medicines. None of the patients had negative attitude toward the pharmacists. About 43.1% of the patients strongly disagreed with unclear instruction of taking medicines. Conclusion: The patients’ satisfaction level with pharmacy service was affected by different pharmacy service-related factors. The management of Wollega University Referral Hospital has to establish and activate information centers to sufficiently provide drug information for the patients and motivate pharmacists morally and financially.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.